secwatch.observer — SEC 8-K summary
======================================

Issuer:     Harmony Biosciences Holdings, Inc. (HRMY)
CIK:        0001802665
Form:       8-K
Filed at:   2024-11-01T23:59:59+00:00
Accession:  0001104659-24-113484
Event type: other_material
Sentiment:  negative
Materiality: 0.65
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Secondary offering of 8M shares by certain shareholders; company receives no proceeds
--------------------------------------------------------------------------------

- Selling Shareholders sold 8,000,000 shares of common stock in a registered public offering.
- Underwriters granted a 30-day option to purchase up to 1,200,000 additional shares.
- J.P. Morgan Securities LLC acted as the sole underwriter for the offering.
- Company will not receive any proceeds from the sale; all net proceeds go to Selling Shareholders.
- Offering closed on November 1, 2024, under an Underwriting Agreement dated October 30, 2024.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1802665/000110465924113484/0001104659-24-113484-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1802665/000110465924113484/tm2427273d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-24-113484

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer